• Modernas Mysterious Medicines

    Forbes | Backed by world-class science, a stealthy biotech has raised $1.9 billion by promising to change medicine forever. A new lawsuit opens a rare window into its secrets.

    Dec 15, 2016

  • Google’s Long Strange Life Span Trip

    MIT Technology Review | Why does a mole rat live 30 years but a mouse only three? With $1.5 billion in the bank, Google's anti-aging spinout Calico is rich enough to find out.

    Dec 15, 2016

  • Goldfinch Bio Aims $55M and Cancer Strategy at Genetic Kidney Disease

    Xconomy | Chronic kidney disease affects more than 10 percent of U.S. adults, and the risk of developing the condition increases with age. New biotech Goldfinch Bio wants to turn genetic research into new therapies.

    Dec 14, 2016

  • New Funds for ONT, Self-Sequencing Challenge from Clive Brown

    Bio-IT World Oxford Nanopore Technologies yesterday announced $126 million in new funding through a private placement of ordinary shares. The investment round was led by new investor GT Healthcare, a pan-Asian fund with special reach in China, and existing investor Woodford Investment Management on behalf of its clients. Clive Brown, Oxford Nanopore's CTO, also released the "Cliveome" yesterday, his own self-sequenced genome.

    Dec 13, 2016